Navigation Links
Biomatrica Secures Financing of $5 Million

SAN DIEGO, Dec. 6, 2012 /PRNewswire/ -- Biomatrica, Inc., a leader in ambient temperature biostability technology, today announced the completion of $5 million in private financing. Biomatrica has developed SampleMatrix® technology which has pioneered recent innovations in ambient storage of biological samples, from purified DNA, RNA, and proteins to complex systems such as tissue, cell lines, biopsies and whole blood. The company's products serve a wide range of customers such as those in the molecular diagnostics, forensics, biomedical research (academic, government and industry), and biobanks.

Biomatrica is also funded by Defense Advanced Research Project Agency (DARPA) for basic technology development to solve some of the hardest biostability problems under the Diagnostics on Demand (DxOD) program.  Within this program, Biomatrica is combining their proprietary biostability technology with the most advanced next generation diagnostics technology enabling their applications on a global scale without cold chain requirements.

"With the new funding, we can accelerate the launch of new technologies and products that will stabilize diagnostic assays at ambient temperature," said Judy Muller-Cohn, Ph.D., CEO and co-founder of Biomatrica. "The growth of next generation sample-to-answer diagnostic tests is rapidly emerging, and Biomatrica can offer custom solutions to companies in the molecular diagnostic space."

"Biomatrica's novel chemical stabilization technology offers significant advantages in costs and performance for ambient temperature assays," said Rolf Muller, Ph.D., CSO and co-founder of Biomatrica. "Funds raised in this round of financing will enable us to strengthen our research initiatives, increase manufacturing capabilities and improve company infrastructure."

About Biomatrica®, Inc.
Biomatrica is a leading provider of innovative products for collecting, preserving, analyzing, storing, and shipping biological samples at ambient temperatures. Biomatrica's product range maintains the integrity of DNA, RNA, saliva, blood, tissues and cells both at the point of collection and point of detection. The unique SampleMatrix® technology enables to utilize ambient temperatures for sample collection, preservation and detection resulting in unparalleled advantages in terms of maintaining sample integrity, ease-of-use and reducing per sample costs. The company's products have been adopted and validated at US government forensic agencies, academic research institutions, global biobanks and diagnostic laboratories. Biomatrica's current products include DNAstable®, DNAgard®, RNAstable® and RNAgard®.

More information is available at or call 1-866-379-6879.

SOURCE Biomatrica
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Delcath Systems, Inc. Secures $20 Million Credit Facility
2. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
3. Benvenue Medical Secures $25 Million Series D Financing
4. PLC Systems Secures Additional Financing For US Clinical Trials And General Working Capital
5. Dr. Jills Foot Pads Secures GSA Schedule and Expands to Service VA and Federal Agencies
6. Alexza Secures a $20 Million Committed Equity Financing Facility with Azimuth Opportunity, L.P.
7. BioMotiv Secures $21 million in Initial Funding
8. ROX Medical secures financing and achieves key milestones in providing minimally-invasive approach for treating hypertension
9. Principia Biopharma Secures $12.5M Second Tranche In Series A Financing, Expands Senior Management Team
10. Flexion Therapeutics Secures $20 Million in Series B Financing
11. Zafgen Secures $21 Million in Series D Financing
Post Your Comments:
(Date:11/25/2015)... DUBLIN , November 25, 2015 ... has announced the addition of the  ... 2015-2019"  report to their offering.  ... announced the addition of the  "Global ...  report to their offering.  ...
(Date:11/24/2015)... 24, 2015  Array BioPharma Inc. (Nasdaq: ... Officer, Ron Squarer , will present at ... York.  The public is welcome to participate in ... BioPharma website.Event:Piper Jaffray Annual Healthcare ConferencePresenter:  , Ron ... 2015Time:1:30 p.m. Eastern Time Webcast: , ...
(Date:11/24/2015)... NEWS, Va. , Nov. 24, 2015  DILON ... they have signed an agreement for DILON to distribute ... geographies across the globe. The signing of this distribution agreement ... Discovery NM750b Molecular Breast Imaging system and is considered ... to provide better healthcare solutions for clinicians and their ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... 2015 , ... The McHenry County law firm of Botto Gilbert Lancaster, ... Francisco J. Botto and Alex C. Wimmer. Attorneys Botto and Wimmer represented the claimant ... (2d) 130884WC. , According to court documents, Adcock testified that on May 10, 2010 ...
(Date:11/25/2015)... ... November 25, 2015 , ... Beddit® has launched a new Android ... The new app features a more intuitive SleepScore™ that rates sleep quality on a ... The SleepScore is created by a proprietary algorithm. Beddit analyzes the data to provide ...
(Date:11/25/2015)... ... ... Today, Mothers Against Drunk Driving (MADD) learned that the number ... first time since 2011. In 2014, there were 9,967 fatalities involving an alcohol impaired ... Highway Traffic Safety Administration (NHTSA), 32,675 people were killed in traffic crashes in 2014. ...
(Date:11/25/2015)... ... 2015 , ... Privately owned Contract Development and Manufacturing Organization ... current state of the art research, development and manufacturing facility outside of Fort ... capacity as well as to support its clients’ growing research and development and ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... has focused on providing comprehensive solutions involving adult stem cell therapies to patients ... officially deemed the “Regenestem” name as a Registered Trademark (RTM). , Organizations are ...
Breaking Medicine News(10 mins):